This paper illustrates the process of defining patent families and outlines the methodology used to build triadic patent families.
This paper explores trade in goods by creating an indicator that estimates CO2 emissions related to domestic demand for 24 countries (responsible for 80% of global CO2 emissions) as a complement to the more common emission indicator used in the Kyoto Protocol
On trouvera dans ce document des informations et un cadre d’analyse qui permettront d’inscrire dans un contexte plus large l’examen des besoins des utilisateurs aux fins du développement de statistiques et d’indicateurs des biotechnologies.
This document reports findings regarding the use of patents data for understanding various dimensions of technical change in health-related areas.
This paper seeks to improve understanding of the links between innovation and competition policy. It is intended to help countries identify ways in which they can design and implement policies that best promote innovation while protecting against anti-competitive behaviour.
Using two waves of the Community Innovation Survey (CIS) for the Netherlands, this paper integrates recent lines of research to estimate the contribution of innovation to manufacturing multifactor productivity (MFP) growth.
While patent data are now readily available for most nations, these data are still of minimal use for economic analysis. The OECD Technology Concordance (OTC) presented in this paper allows researchers to transform IPC-based patent data into patent counts by sector of the economy.
This study investigates the long-term effects of various types of R&D on multifactor productivity growth, which is the spillover effect of R&D. Econometric estimates are conducted on a panel of 16 OECD countries, over the period 1980-98. All results are averages over countries and time.
This paper compares venture capital activity across OECD countries by taking into account international venture capital flows.
This working paper summarises the information gathered by the OECD Secretariat as part of its work to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.